Y-mAbs Therapeutics (YMAB, $13.61) was a top weekly loser, falling -1 to $13.61 per share. Of the 910 stocks analyzed in the Biotechnology Industry throughout the week of May 5/1/2024 - 5/8/2024, 2024, of them (5) exhibited an Uptrend while of them (4) were in a Downtrend.